Détail - canceropole-wordpress

Prospective multi-institutional study of library-based adaptive radiotherapy for cervical cancer: Evaluation of plan-of-the-day selection and population analysis.

Lebret D, Lafond C, Leseur J, Barateau A, Chan Sock Line D, Peignaux K, Mesgouez-Nebout N, Le Blanc-Onfroy M, Hanzen C, Allouache N, Renard-Oldrini S, Le Tinier F, De Crevoisier R, Simon A

J Appl Clin Med Phys. 2025 12;26(12):e70356

Late Toxicities and Quality of Life after a Radiation Boost for Breast DCIS: BONBIS Randomized Trial.

Bourgier C, Mollevi C, Cowen D, Castan F, Lemanski C, Gourgou S, Rivera S, Labib A, Peignaux K, Blanc-Onfroy ML, Benyoucef A, Mege A, Douadi-Gaci Z, Racadot S, Latorzeff I, Schick U, Jacquot S, Massabeau C, Guilbert P, Geffrelot J, Ellis S, Lecouillard I, Breton-Callu C, Richard-Tallet A, Boulbair F, Belliere A, Magné N, Belkacémi Y, Bons F, Fenoglietto P, Azria D

Int J Radiat Oncol Biol Phys. 2025 07 31;:

Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial.

Brion T, Ghodssighassemabadi R, Auzac G, Kirova Y, Racadot S, Benchalal M, Clavier JB, Brunaud C, Fouche-Chand ME, Argo-Leignel D, Peignaux-Casasnovas K, Benyoucef A, Pasquier D, Guilbert P, Blanchecotte J, Tallet-Richard A, Lamrani A, Bergeau M, Bielynite G, Ruffier A, Karamouza E, Michiels S, Rivera S

Radiother Oncol. 2025 03 15;:110849

Clinical practice in stereotactic radiotherapy delivery at treatment unit: a practitioner survey and consensus-based recommendations for multidisciplinary professional development.

Martz N, Marchesi V, Rogé M, Verry C, Clavère P, Peignaux K, Belkacemi Y, Coutte A, Vendrely V, Antoni D, Champeau-Orange E, Thureau S, Aabibou K, Drouin C, Grimon A, Monod C, Farasse P, Supiot S, Faivre JC,

Radiat Oncol. 2025 03 13;20(1):36

Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.

Caluwé A, Bellal S, Cao K, Peignaux K, Remouchamps V, Baten A, Longton E, Bessieres I, Vu-Bezin J, Kirova Y, Gestel DV, Desmoulins I, Ignatiadis M, Romano E, Buisseret L, Piccart M, Vandekerkhove C, Gulyban A, Poortmans P

Radiother Oncol. 2025 03 6;206:110836

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Rossi C, Manson G, Marouf A, Cabannes-Lamy A, Nicolas-Virelizier E, Maerevoet M, Alcantara M, Molina L, Ceraulo A, Poirée M, Galtier J, Diop N, Delette C, Segot A, Dubois S, Waultier A, Bernard S, Noël R, Guidez S, Kohn M, Bailly S, Moatti H, Touati M, Renaud L, Kanoun S, Cottereau AS, Kirova Y, Peignaux K, Dourthe ME, Simonin M, Leblanc T, Quéro L, Krzisch D, Duléry R, Grenier A, Gastinne T, Casasnovas O, Gallamini A, André M, Morschhauser F, Deau B, Fornecker LM, Ghesquières H

Eur J Cancer. 2024 10 22;213:115073

The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies.

Kaidar-Person O, Boersma L, De Brouwer P, Weltens C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Peters M, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Bartelink H, Struikmans H, Fortpied C, Poortmans PM,

Radiother Oncol. 2024 09 26;:110563

CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer.

Allali S, Carton M, Everhard S, Rivera S, Ghannam Y, Peignaux K, Guilbert P, De La Lande B, Chara-Brunaud C, Blanchecotte J, Pasquier D, Racadot S, Bourgier C, Cottu P, André F, Kirova Y

Int J Cancer. 2023 08 12;:

Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925.

Kaidar-Person O, Giasafaki P, Boersma L, De Brouwer P, Weltens C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Bartelink H, Struikmans H, Fortpied C, Poortmans PM,

Radiother Oncol. 2023 05 15;:109698

Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiation.

Mahiou K, Vincent L, Peignaux-Casasnovas K, Costaz H, Padeano MM, Amet A, Dabakuyo S, Mamguem Kamga A, Bengrine-Lefevre L, Coutant C

Cancer Rep (Hoboken). 2023 04 19;:e1823

CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data.

Sarrade T, Allodji R, Ghannam Y, Auzac G, Everhard S, Kirova Y, Peignaux K, Guilbert P, Pasquier D, Racadot S, Bourgier C, Ducornet S, André F, De Vathaire F, Rivera S

Cancers (Basel). 2023 01 25;15(3):

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.

Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S

Breast Cancer Res Treat. 2022 11 23;:

Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort.

Ghannam Y, Di Meglio A, Sarrade T, Jacquet A, Everhard S, Kirova Y, Peignaux K, Guilbert P, Charra-Brunaud C, Blanchecotte J, Bochaton OF, Pasquier D, Racadot S, Bourgier C, Geffrelot J, Benyoucef A, Paris F, Auzac G, Luis IV, Rivera S

Eur J Cancer. 2022 10 10;177:143-153

[Practice changing clinical trials in radiation oncology in 2022].

Antoni D, Claude L, Laprie A, Lévy A, Peignaux K, Rivera S, Schick U

Cancer Radiother. 2022 08 30;:

The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: results from the EORTC 22922/10925 randomised trial.

Kaidar-Person O, Fortpied C, Hol S, Weltens C, Kirkove C, Budach V, Peignaux-Casasnovas K, van der Leij F, Vonk E, Valli M, Weidner N, Guckenberger M, Koiter E, Fourquet A, Bartelink H, Struikmans H, Poortmans P,

Radiother Oncol. 2022 05 11;:

CANTO-RT: Skin toxicities evaluation of a multicenter large prospective cohort of irradiated patients for early-stage breast cancer.

Allali S, Carton M, Sarrade T, Querel O, Jacquet A, Rivera S, Ghannam Y, Peignaux K, Guilbert P, Chara-Brunaud C, Blanchecotte J, Pasquier D, Racadot S, Bourgier C, Labib A, Geffrelot J, Benyoucef A, Paris F, Cottu P, André F, Kirova Y

Int J Cancer. 2022 Apr 30;:

Radiotherapy for endometrial cancer.

Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Hannoun-Lévi JM, Durdux C, Haie-Méder C

Cancer Radiother. 2021 Dec 17;:

Radiotherapy of cervical cancer.

Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Lam Cham Kee D, Durdux C, Haie-Méder C

Cancer Radiother. 2021 Dec 17;:

Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology.

Chargari C, Petit A, Escande A, Peignaux K, Lafond C, Peiffert D, Hannoun-Lévi JM, Durdux C, Haie-Méder C

Cancer Radiother. 2021 Dec 16;:

Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology.

Chargari C, Peignaux K, Escande A, Lafond C, Peiffert D, Petit A, Hannoun-Lévi JM, Durdux C, Haie-Méder C

Cancer Radiother. 2021 Dec 16;:

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.

Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A

Lancet Oncol. 2021 Dec 14;:

Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.

Costaz H, Boulle D, Bertaut A, Rouffiac M, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Causeret S, Loustalot C, Padeano MM, Vincent L, Jankowski C, Arnould L, Coutant C

Bull Cancer. 2021 Nov 24;:

Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.

Bourgier C, Cowen D, Castan F, Lemanski C, Gourgou S, Rivera S, Labib A, Peignaux K, Blanc-Onfroy ML, Benyoucef A, Mege A, Douadi-Gaci Z, Racadot S, Latorzeff I, Schick U, Jacquot S, Massabeau C, Guilbert P, Geffrelot J, Ellis S, Lecouillard I, Breton-Callu C, Richard-Tallet A, Boulbair F, Cretin J, Belkacémi Y, Bons F, Azria D, Fenoglietto P

Radiother Oncol. 2021 Sep 24;:

[Role of radiotherapy in haematology].

Peignaux-Casasnovas K, Truc G, Rossi C, Casasnovas O

Cancer Radiother. 2021 Aug 28;:

Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925.

Poortmans PM, Struikmans H, De Brouwer P, Weltens C, Fortpied C, Kirkove C, Budach V, Peignaux-Casasnovas K, van der Leij F, Vonk E, Valli M, van Tienhoven G, Weidner N, Noel G, Guckenberger M, Koiter E, van Limbergen E, Engelen A, Fourquet A, Bartelink H,

J Natl Cancer Inst. 2021 Jul 28;:

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease.

Bolla M, Neven A, Maingon P, Carrie C, Boladeras A, Andreopoulos D, Engelen A, Sundar S, van der Steen-Banasik EM, Armstrong J, Peignaux-Casasnovas K, Boustani J, Herrera FG, Pieters BR, Slot A, Bahl A, Scrase CD, Azria D, Jansa J, O'Sullivan JM, Van Den Bergh ACM, Collette L,

J Clin Oncol. 2021 Jul 26;:JCO2100855

[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial].

Charra-Brunaud C, Salleron J, Menoux I, Peignaux K, Ducassou A, Petit A, Pommier P, Barillot I, Serre AA, Thomas L, Delannes M, Thibouw D, Antoni D, Renard S, Peiffert D

Cancer Radiother. 2021 Jul 20;:

[Extreme hypofractionated radiation therapy for pancreatic cancer].

Rouffiac M, Ghirardi S, Chevalier C, Bessières I, Peignaux-Casasnovas K, Truc G, Créhange G

Cancer Radiother. 2021 Jul 17;:

[Lung cancer and pulmonary metastasis treated by stereotactic radiosurgery: Evaluation of the relevance of realisation of 3 4D CT by the RPM technique].

Khadige M, Peiffert D, Buchheit I, Salleron J, Peignaux-Casasnovas K, Bidault F, Martin E

Cancer Radiother. 2020 Dec 26;:

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.

Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Van Limbergen EF, Engelen A, De Brouwer P, Struikmans H, Bartelink H,

Lancet Oncol. 2020 Nov 2;:

A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study.

Claude L, Morelle M, Mahé MA, Pasquier D, Boisselier P, Bondiau PY, Touboul E, Peignaux-Casasnovas K, Martel-Lafay I, Gassa F, Perrier L, Dussart S, Beckendorf V

Br J Radiol. 2020 Sep 24;:20200256

Outcomes of concurrent radiotherapy with weekly docetaxel and platinum-based chemotherapy in stage III non-small-cell lung cancer.

Kaderbhaï CG, Coudert B, Bertaut A, Adnet J, Favier L, Lagrange A, Peignaux-Casasnovas K, Mettey L, Tharin Z, Foucher P, Martin E

Cancer Radiother. 2020 May 18;:

[Strategies in case of metastatic sentinel lymph node in breast cancer].

Costaz H, Rouffiac M, Boulle D, Arnould L, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Vincent L, Jankowski C, Coutant C

Bull Cancer. 2019 Nov 4;:

Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.

Clément-Zhao A, Tanguy ML, Cottu P, De La Lande B, Bontemps P, Lemanski C, Baumann P, Savignoni A, Levy C, Peignaux K, Reynaud-Bougnoux A, Gobillion A, Kirova Y

PLoS ONE. 2019 ;14(8):e0221816

Compliance and outcome of elderly patients treated in the Concurrent ONce daily VErsus twice-daily RadioTherapy (CONVERT) trial.

Christodoulou M, Blackhall F, Mistry H, Leylek A, Knegjens J, Remouchamps V, Martel-Lafay I, Farré N, Zwitter M, Lerouge D, Pourel N, Janicot H, Scherpereel A, Tissing-Tan C, Peignaux K, Geets X, Konopa K, Faivre-Finn C

J Thorac Oncol. 2018 Oct 11;:

[Hodgkin lymphoma and target definition guidelines].

Peignaux K, Gonzague-Casabianca L

Cancer Radiother. 2018 Aug 6;:

Salvage brachytherapy as a modern reirradiation technique for local cancer failure: The Phoenix is reborn from its ashes.

Quivrin M, Peignaux-Casasnovas K, Martin É, Rouffiac M, Thibouw D, Chevalier C, Vulquin N, Aubignac L, Truc G, Créhange G

Cancer Radiother. 2018 May 30;:

Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.

Dautruche A, Belin L, Cottu P, Bontemps P, Lemanski C, de la Lande B, Baumann P, Missohou F, Lévy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Pernin V, Kirova Y

Cancer Radiother. 2018 Apr 9;:

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.

Bourgier C, Castan F, Riou O, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin EM, Azria D

Oncotarget. 2018 Mar 20;9(21):15757-15765

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Eliade M, Skrzypski J, Baurand A, Jacquot C, Bertolone G, Loustalot C, Coutant C, Guy F, Fumoleau P, Duffourd Y, Arnould L, Delignette A, Padéano MM, Lepage C, Raichon-Patru G, Boudrant A, Bône-Lépinoy MC, Villing AL, Charpin A, Peignaux K, Chevrier S, Vegran F, Ghiringhelli F, Boidot R, Sevenet N, Lizard S, Faivre L

Oncotarget. 2017 Jan;8(2):1957-1971

[Radiotherapy of cervix and endometrial carcinoma].

Barillot I, Haie-Méder C, Charra Brunaud C, Peignaux K, Kerr C, Thomas L

Cancer Radiother. 2016 Sep;20 Suppl:S189-95

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

Azria D, Riou O, Castan F, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Bourgier C, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Kramar A, Gourgou S, Pèlegrin A, Fenoglietto P, Ozsahin EM

EBioMedicine. 2015 Dec;2(12):1965-73

Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.

Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Bollet M, Vago NA, Dendale R, Campana F, Fourquet A, Kirova YM

Br J Radiol. 2015 Apr;88(1048):20140800

Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer.

Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Bougnoux P, Denis F, Bollet M, Dendale R, Vago NA, Campana F, Fourquet A, Kirova YM

Breast. 2014 Dec;23(6):816-20

Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.

Mornex F, Peignaux K, Germain T, Wautot V, Chouaki N, Bourayou N, Tourani JM

Lung Cancer. 2013 Apr;80(1):68-74

Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, Siesling S, Torrella-Ramos A, Voogd AC, Aareleid T, Ardanaz E, Berrino F, Bielska-Lasota M, Bolick S, Cirilli C, Colonna M, Contiero P, Cress R, Crocetti E, Fulton JP, Grosclaude P, Hakulinen T, Izarzugaza MI, Malmstrom P, Peignaux K, Primic-Zakelj M, Rachtan J, Safaei Diba C, Sanchez MJ, Schymura MJ, Shen T, Traina A, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP

Int J Cancer. 2013 Mar 1;132(5):1170-81

Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.

Crehange G, Mirjolet C, Gauthier M, Martin E, Truc G, Peignaux-Casasnovas K, Azelie C, Bonnetain F, Naudy S, Maingon P

Radiother Oncol. 2012 May;103(2):244-6

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Azelie C, Gauthier M, Mirjolet C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Chamois J, Maingon P, Crehange G

Radiat Oncol. 2012 Sep 17;7:158

Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.

Crehange G, Bonnetain F, Peignaux K, Truc G, Blanchard N, Rat P, Chauffert B, Ghiringhelli F, Maingon P

Crit Rev Oncol Hematol. 2010 Sep;75(3):235-42

[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]

Remonnay R, Morelle M, Pommier P, Haie-Meder C, Quetin P, Kerr C, Delannes M, Castelain B, Peignaux K, Kirova Y, Romestaing P, Williaume D, Krzisch C, Thomas L, Lang P, Baron MH, Cussac A, Lesaunier F, Maillard S, Barillot I, Charra-Brunaud C, Carrere MO, Peiffert D

Cancer Radiother. 2010 Jun;14(3):161-8

Variation in 'standard care' for breast cancer across Europe: A EUROCARE-3 high resolution study.

Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Torrella-Ramos A, Bielska-Lasota M, Aareleid T, Ardanaz E, Colonna M, Crocetti E, Danzon A, Federico M, Garau I, Grosclaude P, Hedelin G, Martinez-Garcia C, Peignaux K, Plesko I, Primic-Zakelj M, Rachtan J, Tagliabue G, Tumino R, Traina A, Tryggvadottir L, Vercelli M, Sant M

Eur J Cancer. 2010 Mar 16.

Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.

Ligey A, Gentil J, Crehange G, Montbarbon X, Pommier P, Peignaux K, Truc G, Maingon P

Radiother Oncol. 2009 Dec;93(3):483-7

[Potential combination of target therapy and radiation therapy in GI tract cancers]

Maingon P, Crehange G, Peignaux K, Truc G

Cancer Radiother. 2008 Jan;12(1):25-30

Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.

Crehange G, Maingon P, Peignaux K, N'guyen TD, Mirabel X, Marchal C, Verrelle P, Roullet B, Bonnetain F, Bedenne L

J Clin Oncol. 2007 Nov 1;25(31):4895-901.

[Is a linac able to do better than tomotherapy or Cyberknife?]

Maingon P, Truc G, Peignaux K, Crehange G

Cancer Radiother. 2007 Nov;11(6-7):345-8

Intensity modulated radiation therapy

Maingon P, Truc G, Peignaux K, Crehange G, Lagpeau E

Oncologie. 2007 Jun;9(6):417-21

Preoperative radiotherapy in elderly patients with rectal cancer

Lorchel F, Peignaux K, Crehange G, Bosset M, Puyraveau M, Mercier M, Bosset JF, Maingon P

Gastroenterol Clin Biol. 2007 Apr;31(4):436-41.

Clinical assessment of the use of the Sonarray system for daily prostate localization.

Peignaux K, Truc G, Barillot I, Ammor A, Naudy S, Crehange G, Maingon P

Radiother Oncol. 2006 Nov;81(2):176-8

[Implementation of transabdominal ultrasound image guided conformal intensity modulated radiotherapy].

Naudy S, Peignaux K, Brenier JP, Crehange G, Arnaud A, Truc G, Bidault F, Maingon P

Cancer Radiother. 2006 Nov;10(6-7):388-93

[High precision radiotherapy with ultrasonic imaging guidance].

Peignaux K, Crehange G, Truc G, Barillot I, Naudy S, Maingon P

Cancer Radiother. 2006 Sep;10(5):231-4

[Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor].

Benchalal M, Boisselier P, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P

Bull Cancer. 2006 Mar 1;93(3):303-13.

[Conformal radiation therapy with or without intensity modulation in the treatment of localized prostate cancer].

Maingon P, Bolla M, Truc G, Bosset M, Peignaux K, Ammor A

Cancer Radiother. 2005 Nov;9(6-7):382-7

Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.

Benchalal M, Le Prise E, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P

Cancer. 2005 Jul 15;104(2):240-50.

Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.

Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, Lagrange JL, Alzieu C, Gerard JP

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):479-85.

Dr PEIGNAUX Karine

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Publications

Retrouvez aussi